Braun Samuel J 13D and 13G filings for Zevra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-12 4:03 pm Sale |
2022-01-04 | 13G | Zevra Therapeutics, Inc. ZVRA |
Braun Samuel J | 3,021,660 8.600% |
-355,900 (-10.54%) |
Filing |
| 2021-12-01 08:25 am Purchase |
2021-11-30 | 13D | Zevra Therapeutics, Inc. ZVRA |
Braun Samuel J | 3,377,560 9.600% |
222,560 (+7.05%) |
Filing |
| 2021-05-17 4:43 pm Purchase |
2021-05-10 | 13G | Zevra Therapeutics, Inc. ZVRA |
Braun Samuel J | 3,155,000 11.100% |
1,098,500 (+53.42%) |
Filing |
| 2021-04-19 5:12 pm Purchase |
2021-04-09 | 13G | Zevra Therapeutics, Inc. ZVRA |
Braun Samuel J | 2,056,500 7.200% |
2,056,500 (New Position) |
Filing |